A recall of 300 boxes of the male energy supplement WEFUN has been issued due to a hidden ingredient in the drug. The supplement, touted as a safe and natural testosterone booster, contains undeclared Sildenafil, a substance not approved for this use by the FDA. When taken with other medications, Sildenafil can cause serious interactions, including death. As of the writing of this notice, no adverse effects have yet been reported.

When purchasing supplements online, consumers should take great care to research the ingredients and company thoroughly. This is not the first recall of this kind. In February 2023, we reported a recall of a similar supplement, PrimeZEN Black 6000, which also contained Sildenafil. Men who require supplementation for energy, testosterone supplementation, assistance with erectile dysfunction, or any other health concern should seek medical advice from a licensed physician.

SUMMARY

Date of Recall:

Announced: August 25, 2023

Public Notification: September 5, 2023

Name(s) of Drug:

WEFUN Male Supplement

Company Name:

WEFUN Inc.

Drug Indication:

Male Energy Enhancement

Male Testosterone Supplement

Product Description

WEFUN supplements were sold nationwide at online distributors such as www.amazon.com, www.eshoponlineusa.com, and www.wefunonline.com. The products were delivered in blue cardboard boxes, each containing ten capsules, and labeled with the brand name.

Reason for Recall

Sildenafil is a substance approved by the FDA for use in certain drugs, including those to treat erectile dysfunction. The substance is not approved for use in over-the-counter supplements due to its propensity for igniting a dangerous interaction with other medications, particularly those taken for heart conditions, diabetes, and cholesterol.

Impacts

Consumers who take WEFUN may experience a dangerous interaction with their other medications. Symptoms of an interaction with Sildenafil include:

• Hypotension (low blood pressure)
• Weakness
• Lightheadedness
• Loss of Consciousness
• Confusion
• Blurred vision
• Nausea
• Vomiting
• DEATH

Medications most likely to interact with Sildenafil include:

• Nitroglycerin
• Nitrostat
• Nitromist
• Nitrolingual Pumpspray
• Nitro-Bid
• Nitropress
• Nitroprusside
• Nitro-Dur
• Transderm-Nitro
• Nitro-Time
• Isosorbide Mononitrate
• Dinitrate
• Isordil
• Isordil Titradose
• Dilatrate-SR
• Amyl Nitrite
• Amyl Nitrate

Lot Information

WEFUN consumers should immediately locate the package and compare the information on the box with the chart below. If the lot number and expiration date match, further steps are required to dispose of the drug and report adverse effects properly.

FDA.gov

Have you found that your supplement is part of the recall? Here’s what you should do:

Consumers

1. Seek medical attention immediately if you believe you are experiencing an adverse event.
2. Notify your doctor and report any changes in your health.
3. Monitor your health for any adverse symptoms and notify your physician if any concerns are noted.
4. Consumers may contact WEFUN Inc. at 1 (929) 509-7343. They are available daily from 9:00 a.m. to 7:00 p.m. (EST). Consumers can also reach them via email at wefun2022@gmail.com.
5. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
6. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Retailer

1. Examine all inventory and remove stock affected by the recall immediately.
2. Contact WEFUN Inc. at 1 (929) 509-7343. Retailers can also reach them via email at wefun2022@gmail.com. Notify them of any recalled batches that have already been distributed to consumers.
3. Notify affected consumers of recalled batches that they have already or will receive.
4. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

Wholesaler

1. Examine all inventory and remove stock affected by the recall immediately.
2. Contact WEFUN Inc. at 1 (929) 509-7343. Wholesalers can also reach them via email at wefun2022@gmail.com. Notify them of any recalled batches that have already been shipped to retailers.
3. Notify affected retailers of recalled batches that they have already or will receive.
4. Contact MedWaste Management for information and assistance with disposing of the recalled medication.

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog to spread useful and practical information to help you stay safe, smart, and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

Tammy McKinney, RN, creator of HelpfulHospiceNurse, is a healthcare writer and seasoned registered nurse. With experience in acute care, long-term care, rehabilitation, drug & alcohol, and hospice & palliative care, she combines her medical understanding with her love for writing to educate and inform the public on various health-related topics. You can view a snippet of her portfolio here or contact her directly on LinkedIn!

An immediate recall has been issued by The Harvard Drug Group after two of their medications, Dronabinol and Ziprasidone Hydrochloride were involved in a labeling mix-up. It was reported that a package of Dronabinol Capsules was incorrectly labeled as Ziprasidone Hydrochloride. At this time, only a single lot of each medication is being recalled, as it is thought that other lots have been labeled correctly.

At the time of the writing of this notice, no adverse events have been reported as a result of the mix-up.

SUMMARY

Date of Recall:

Announced: June 13, 2023

Public Notification: June 14, 2023

Name(s) of Drug:

Dronabinol Capsules, USP, 2.5mg

Ziprasidone Hydrochloride Capsules, 20mg

Company Name:

The Harvard Drug Group, LLC

d/b/a Major Pharmaceutical

d/b/a Rugby Laboratories

Drug Indication:

Dronabinol (nausea/vomiting during chemotherapy, treatment of weight loss, and lack of appetite in HIV patients)

Ziprasidone Hydrochloride (schizophrenia, bipolar disorder, other mood disorders)

Product Description

Dronabinol is a white capsule, imprinted with “M2.”

Ziprasidone Hydrochloride is a capsule with a lavender opaque end and a flesh opaque body. “RDY is printed on the lavender end and “356” is printed on the flesh end.

Reason for Recall

While no adverse events have yet been reported, the mislabeling of the medication can result in consumers receiving medications that they are not prescribed to take and missing doses of their necessary medications.

Impacts

Dronabinol is a man-made form of marijuana. While the side effects from taking it are typically mild, they can include dizziness, drowsiness, an exaggerated feeling of well-being, stomach pain, fainting, fast heartbeat (tachycardia), mood changes, hallucinations, and paranoia. For those who are prescribed the medication, symptoms such as nausea, lack of appetite, and vomiting may return when doses are missed. Furthermore, replacing this medication with Ziprasidone can result in further increased nausea and decreased appetite.

Ziprasidone is an antipsychotic and works by binding to serotonin and dopamine receptors in the brain, thus changing the balance of those chemicals. Its side effects include headache, restlessness, loss of appetite, constipation, diarrhea, cough, runny nose, weight gain, dizziness, stomach pain, and others. These side effects can be quite dangerous for patients who are not prescribed the medication. Furthermore, for patients who are on the medication, sudden discontinuation of their usual dose can result in dangerous withdrawal symptoms such as panic attacks, mood swings, hallucinations, anorexia, vomiting, insomnia, confusion, weakness, and suicidality.

Lot Information

Consumers who use the medications listed above should locate their medication’s package and compare the brand name, dosage, lot number, NDC, and expiration date.

FDA.gov

Have you found that your medication is part of the recall? Here’s what you should do:

Consumers

If you find that your lot of medication is part of this recall, do the following:

1. Call your doctor right away. Ask for a new prescription to replace your recalled medication and report any symptoms that you’re experiencing.
2. Continue to monitor your health for any adverse symptoms over the next week and notify your physician if any concerns are noted.
3. Consumers may contact Sedgwick, Inc at 1-888-759-6904. They are available Mon-Fri from 9:00am to 5:00pm (EST). They are also available via email at harvarddrug6068@sedgwick.com.
4. If you are currently experiencing or have experienced an adverse reaction to this medication (listed above), notify your physician immediately and notify the FDA by calling 1-800-332-1088 or completing an online reporting form.
5. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Retailer

1. Examine all inventory and remove stock that is affected by the recall immediately.
2. Contact Sedgwick, Inc at 1-888-759-6904 or you can utilize harvarddrug6068@sedgwick.com to contact them via email. Notify them of any recalled batches that have already been sold to consumers.
3. Notify affected consumers of recalled batches that they have already or will receive.
4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

Wholesaler

1. Examine all inventory and remove stock that is affected by the recall immediately.
2. Contact Sedgwick, Inc at 1-888-759-6904 or you can utilize harvarddrug6068@sedgwick.com to contact them via email. Notify them of any recalled batches that have already been shipped to retailers.
3. Notify affected retailers of recalled batches that they have already or will receive.
4. Contact MedWaste Management for information and/or assistance with disposing of the recalled medication.

We are MedWaste Management – California’s medical waste disposal experts!

Established in 2008, MedWaste Management fills a need for compliant and safe medical waste disposal to the healthcare industry and the general public alike. We publish this blog in order to spread useful and practical information to help you stay safe, smart and healthy!

Call us with any questions or to start service at (866) 254-5105. We are always happy to help!

Check out our services and other great resources in the links below.

Medical Waste Disposal Services

MedWaste’s Blog Index

Medical Waste Regulations

MedWaste’s Product Store

Learn How To Properly Manage & Dispose of Household Medical Waste

Tammy McKinney, RN, creator of HelpfulHospiceNurse is a healthcare writer and seasoned registered nurse. With experience in acute care, long-term care, rehabilitation, drug & alcohol, and hospice & palliative care, she combines her medical understanding with her love for writing to educate and inform the public on various health-related topics. You can view a snippet of her portfolio here or reach out to her directly on LinkedIn!